Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

The entrepreneur and thinker presented a framework for how artificial intelligence and humanity might productively evolve together.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Think back to middle school algebra, like 2 a + b. Those letters are parameters: Assign them values and you get a result. In ...

A group of tech executives, app developers and Silicon Valley philosophers is seeking to streamline the messy matters of the ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, ...

Broadcom enters 2026 at an inflection point, with strong tailwinds from its ASIC and Networking segments. Read why AVGO stock ...

Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...

India, Dec. 21 -- Congress Lok Sabha MP Karti Chidambaram said he has no regrets about not knowing Hindi, stating that he never had the opportunity to learn the language and that there was no ...

Kylie Jenner and Travis Scott end their on-again, off-again relationship in early January. (Meaning she’s fully single heading into 2023.) A source at the time tells Us Weekly, “Kylie and Travis are ...